Ocean Biomedical Inc (OCEA) Return on Investment ROI from the first quarter of 2025 to first quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ocean Biomedical Inc   (NASDAQ: OCEA)


Ocean Biomedical Inc's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ocean Biomedical Inc's ROI in the first quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Ocean Biomedical Inc 's return on investment (ROI) in its first quarter of 2025

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -25 -98 -31 -29 -27
Return On Investment (TTM) - - - - -
OCEA's Overall Ranking # 4401 # 4642 # 4248 # 4645 # 4779
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -27 -8 -25 -35 -29

OCEA Company Profile >> Back to OCEA Roi Comparisons >> See Annual OCEA Return On Investment



Return On Investment OCEA's Ranking
Within: No.
Industry # 380
Sector # 804
Overall # 4401

Return On Investment Statistics
High Average Low
-0.16 %
-153.49 %
-695.3 %
  (Sep 30 2023)







Financial Statements
Ocean Biomedical Inc's I. Quarter Investments $ -25 Millions OCEA's Balance sheet
Ocean Biomedical Inc's I. Quarter Income $ -7 Millions Quarterly OCEA's Income Statement
OCEA's Income by Division See OCEA's Income by Division


OCEA Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions -98 -25 107 108 0
Y / Y Investment Growth - - -0.88 % - -
Net Income in Millions -9 -114 -1 -1 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - -0.89 % -0.52 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OCEA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OCEA's Competitors
Subscribers only: Roi for Ocean Biomedical Inc's Suppliers
Subscribers only: Return On Investment for OCEA's Customers

Other Ratios
OCEA's Roa OCEA's Inventory Turnover Ratio OCEA's Growth Rates OCEA's Dividend Statistics
OCEA's Profitability Ratios OCEA's Asset Turnover Ratio OCEA's Dividend Growth
OCEA's Roe OCEA's Valuation Ratios OCEA's Financial Strength Ratios OCEA's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI
Cytomx Therapeutics Inc   139.64 %
Camp4 Therapeutics Corporation  136.24 %
Alumis inc   113.83 %
Stablecoin Development Corporation  110.75 %
Earth Science Tech Inc   100.58 %
Oak Woods Acquisition Corp  93.88 %
Avalo Therapeutics Inc   88.86 %
Tao Synergies Inc   78.95 %
Synlogic Inc   73.65 %
Novavax inc   71.31 %
Longduoduo Co Ltd  62.85 %
Medinotec Inc   60.77 %
Exelixis Inc   59.41 %
Gridai Technologies Corp  58.38 %
Adma Biologics Inc   53.77 %
Bluebird Bio Inc   52.44 %
Seres Therapeutics Inc   52.22 %
Pharmacyte Biotech Inc   48.77 %
Agios Pharmaceuticals Inc   48.46 %
Dariohealth Corp   44.97 %
Sbc Medical Group Holdings Incorporated  41.74 %
Champions Oncology Inc   41.16 %
Ptc Therapeutics inc   40.79 %
Rigel Pharmaceuticals Inc  39.96 %
Mettler toledo International Inc   39.75 %
Idexx Laboratories Inc  39.40 %
Edwards Lifesciences Corporation  38.53 %
Puma Biotechnology Inc   34.10 %
Hims and Hers Health Inc   34.04 %
Medpace Holdings Inc   33.49 %

Date modified: 2026-09-26T07:40:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.